Avelo

Based in Switzerland, Avelo is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Avelo develops a non-invasive breath aerosol collection kit (AveloMask) that captures viruses and bacteria from the respiratory tract and transfers the sample into a stabilizing buffer for analysis with existing molecular/PCR tests. The solution is intended to improve diagnosis of tuberculosis and other respiratory infections by enabling painless lower-respiratory sampling outside of invasive procedures.